Mehrabi Masomeh, Alibakhshi Reza, Fathollahi Soheila, Farshchi Mohammad Reza
Medical Genetics Laboratory, Kermanshah University of Medical Sciences , Kermanshah , Iran.
Hemoglobin. 2013;37(6):544-52. doi: 10.3109/03630269.2013.814036. Epub 2013 Aug 5.
β-Thalassemia (β-thal) is a hereditary autosomal disorder with decreased or absent β-globin chain synthesis. Two hundred and one unrelated β-thal carriers, attending the Kermanshah Medical Genetics Laboratory, Kermanshah, Iran, were investigated for β-globin gene mutations by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and direct sequencing. Eighteen different mutations were identified in these subjects. Four of the mutations accounted for about 75.0% of the studied cases. IVS-II-1 (G>A) was the most frequent (45.8%) followed by codons 8/9 (+G) (15.9%), IVS-I-110 (G>A) (8.0%), IVS-I-6 (T>C) (5.5%), IVS-I-1 (G>A) (3.5%) and codon 44 (-C) (3.5%); the remaining 12 mutations were present with a frequency less than 3.0%. The mean corpuscular volume (MCV) values for males and females were 63.7 ± 3.7 and 63.2 ± 3.2 fL, respectively, while these values were 19.3 ± 1.6 and 19.3 ± 1.4 pg for mean corpuscular hemoglobin (Hb) (MCH). The mean Hb A2 values for males and females were 4.4 ± 0.5 and 4.1 ± 0.6%, respectively. This study provides a distribution guide for β-thal mutations in Kermanshah Province, West Iran.
β地中海贫血(β-thal)是一种常染色体隐性遗传性疾病,其β珠蛋白链合成减少或缺失。对伊朗克尔曼沙赫克尔曼沙赫医学遗传学实验室的201名无关β地中海贫血携带者,采用扩增阻滞突变系统-聚合酶链反应(ARMS-PCR)和直接测序法检测β珠蛋白基因突变。在这些受试者中鉴定出18种不同的突变。其中4种突变约占研究病例的75.0%。IVS-II-1(G>A)最为常见(45.8%),其次是密码子8/9(+G)(15.9%)、IVS-I-110(G>A)(8.0%)、IVS-I-6(T>C)(5.5%)、IVS-I-1(G>A)(3.5%)和密码子44(-C)(3.5%);其余12种突变的出现频率低于3.0%。男性和女性的平均红细胞体积(MCV)值分别为63.7±3.7和63.2±3.2 fL,而平均红细胞血红蛋白(Hb)(MCH)值分别为19.3±1.6和19.3±1.4 pg。男性和女性的平均Hb A2值分别为4.4±0.5和4.1±0.6%。本研究为伊朗西部克尔曼沙赫省β地中海贫血突变提供了分布指南。